Gastrointestinal Market Research Reports & Industry Analysis
While many of these illnesses are chronic and can only be treated medically, more holistic and natural approaches are being used more frequently to prevent and manage gastrointestinal disorders. Many healthcare providers are recommending stress management, a healthy diet, and exercise to prevent and manage symptoms.
Exercise has shown to decrease the risk of colon cancer, minimize constipation and improve overall GI health. Even minimal exercise paired with a healthy diet of fruits, vegetables, low fat protein and avoidance of red meat, animal fat, and processed meats, can go a long way in preventing colon cancer and other GI diseases.
It is known that psychological stress can aggravate symptoms of Crohn’s disease, irritable bowel syndrome, and ulcerative colitis. Taking a mind-body approach to health can help these patients manage their illnesses. Techniques such as yoga, meditation, massage, and acupuncture can lower stress and in turn reduce bowel symptoms. Doctors also recommend an anti-inflammatory diet (omega-3 fatty acids, fruits & vegetables, and protein rich food like fish, chicken and soy) for people suffering from Crohn’s disease.
Gastrointestinal Industry Research & Market Reports
-
Global Celiac Diseases Drugs Market 2025-2029
... diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
Gastroesophageal Reflux Disease (GERD) Global Market Report 2025
... disease (gerd) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Gastrointestinal Devices Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Gastrointestinal OTC Drugs Market by Drug Class (Laxatives, Gastrointestinal Cancer Treatments, Gastric Acid Reducers, Anti-Diarrheal, Proton Pump Inhibitors, H2 Inhibitors, Gastric Acid Neutralizers, Bowel Anti-Inflammatory, Anti-Emetics), Indication (Gastroesophageal Reflux Disease (GERD) or Heartburn, Constipation, Diarrhea, Motion Sickness, and Others), End User (Hospitals, Clinics, and Others), and Region 2025-2033
... 2025-2033. The rising prevalence of gastrointestinal disorders, increasing awareness among the masses regarding digestive health, and the recent development of advanced formulations represent some of the key factors driving the market. Gastrointestinal over-the-counter (OTC) drugs ... Read More
-
Gastroesophageal Reflux Disease Therapeutics Global Market Report 2025
... disease therapeutics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Gastrointestinal Endoscopy Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Constipation Treatment Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Gastric Volvulus Treatment Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Systemic Antifungals Market Size, Share, By Drug Classes (Azoles, Echinocandins, Polyenes, and Others), Indication (Aspergillosis, Histoplasmosis, Gastrointestinal Candidiasis, Blastomycosis, Fungal Endocarditis, and Others), End-Users (Hospital & Specialty Clinics, Ambulatory Surgical Centers, Research Institute & Clinical Trial Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035
... share, by top players, by type, by the end user, and by region. Systemic Antifungals Market Size Statistics Till 2035, the market is envisioned to flourish at USD 36.8 Billion. The systemic antifungals market size ... Read More
-
Global Gastrointestinal Products Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
2025 Diseases of the Digestive System Global Market Size & Growth Report with Updated Analysis & Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the digestive system ... Read More
-
Medical Nutrition Market, By Nutrition Type (Proteins, Carbohydrates, Multivitamins & Antioxidants, Amino Acids, Fibers, Minerals, and Others), By Indication (Diabetes, Cancer, Gastrointestinal Diseases, Metabolic Syndromes, and Others), By Patient Type (Infant Nutrition, Adult Nutrition, and Geriatric Nutrition), By Route of Administration (Oral, Enteral, and Parenteral), By End User (Hospitals, Home Care Settings, Long Term Care, and Ambulatory Surgical Centers), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... seen significant growth over the past decade driven by the increasing prevalence of chronic diseases and growing elderly population worldwide who are more susceptible to nutritional deficiencies. Various factors, such as the rising consumer awareness ... Read More
-
Gastrointestinal Stents Market Report by Product Type (Biliary Stents, Duodenal Stents, Colonic Stents, Pancreatic Stents, Esophageal Stents), Technology Type (Anti-Migratory Stents, Drug-Eluting Stents, Radioactive Stents, Anti-Reflux Stents, Shape-Modified Stents, and Others), Material (Plastic Stents, Self-Expanding Metal Stents, Covered Self-Expandable Metallic Stents, Biodegradable or Drug Eluting Stents), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centres, and Others), and Region 2025-2033
... A gastrointestinal stent refers to an artificial tube graft that is inserted in the body to prevent blockages in the gullet, stomach and small intestine. It is an expandable metal or a plastic mesh tube ... Read More
-
Short Bowel Syndrome (SBS)
... 2030, growing at a CAGR of 21.6% over the analysis period 2024-2030. GLP-2 Drug Class, one of the segments analyzed in the report, is expected to record a 23.2% CAGR and reach US$5.4 Billion by ... Read More
-
Gastrointestinal Videoscopes
... CAGR of 6.4% over the analysis period 2024-2030. Hospitals Application, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$5.3 Billion by the end of the analysis ... Read More
-
Ulcerative Colitis Therapeutics
... at a CAGR of 4.3% over the analysis period 2024-2030. Oral Administration, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$5.6 Billion by the end of ... Read More
-
Antacids
... 2.2% over the analysis period 2024-2030. Proton Pump Inhibitors, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.2 Billion by the end of the analysis period. ... Read More
-
Bariatric (Obesity) Surgical Devices
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Sleeve Gastrectomy, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$3.6 Billion by the ... Read More
-
Inflammatory Bowel Disease (IBD) Therapeutics
... Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. TNF Inhibitor Drugs, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$14.0 ... Read More
-
Irritable Bowel Syndrome (IBS) Therapeutics
... Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. IBS-D Therapeutics, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion ... Read More
-
Gastrointestinal Therapeutics
... CAGR of 5.1% over the analysis period 2024-2030. Crohn`s Disease End-Use, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$19.0 Billion by the end of the ... Read More
-
Peptic Ulcer Drugs
... at a CAGR of 2.2% over the analysis period 2024-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$2.6 Billion by the end of the ... Read More
-
Digestive Enzyme Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Animal Source, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$817.7 Million by the end of ... Read More
-
Gastrointestinal Stents
... CAGR of 5.9% over the analysis period 2024-2030. Biliary Stents, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$382.2 Million by the end of the analysis ... Read More
-
Gastroparesis Drugs
... CAGR of 4.8% over the analysis period 2024-2030. Idiopathic Gastroparesis Drugs, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$4.3 Billion by the end of the ... Read More
Research Assistance
